Will ENMD capitalize on PR of Mayo clinic results AND lead article in the journal Cancer Research? These developments will drive herds of potential investors who don't know squat about ENMD to the website. The news IMO should be front and center at www.entremed.com
Panzem's first killer indication in cancer could be as an injectable breast ca anti-metastatic for osteolysis. Who woulda thunk it?
Market Data 
Markets 
AI
